Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Q1 2022 Earnings Conference Call May 16, 2022 8:30 AM ET
Company Participants
Alex Lobo - Stern, Investor Relations
Kevin Boyle - Chief Executive Officer
Drew Deniger - Vice President, Research and Development
Mike Wong - Vice President, Finance
Conference Call Participants
Nick Abbott - Wells Fargo
Prakhar Agrawal - Cantor Fitzgerald
Thomas Flaten - Lake Street Capital Markets
Operator
Good day and thank you for standing by. Welcome to Alaunos Therapeutics First Quarter 2022 Financial Results Conference Call.
At this time, all participants are in a listen-only mode. [Operator Instructions] I'd now like to hand the call over to your speaker today, Mr. Alex Lobo, Investor Relations. Mr. Lobo, the floor is yours.
Alex Lobo
Good afternoon and welcome to Alaunos Therapeutics first quarter 2022 financial results conference call and audio webcast. With me today are Kevin Boyle Senior, Alaunos Therapeutics', Chief Executive Officer, Drew Deniger, Vice President of Research and Development and Mike Wong, Vice President of Finance.
Earlier this morning, Alaunos issued a press release announcing financial results for the three months ended March 31, 2022. We encourage everyone to read today's press release, as well as the Alaunos quarterly report on Form 10-Q for the quarter ended March 31, 2022, which is filed this morning with the SEC. The company's press release and quarterly report will also be available one the Alaunos' website at Alaunos.com.
In addition, this conference call is being webcast through the Investor Relations section of the company's website and will be archived there for future reference. Please note that certain information discussed on today's call is covered under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Participants are cautioned that this conference call contains time sensitive information that is accurate only as of the date of this live broadcast May 16, 2022. Actual results could differ materially from those stated or implied by forward-looking statements made today due to risks and uncertainties associated with the company's business. Information on potential risks and uncertainties are set forth in our most recent public filings with the SEC at ec.gov. The company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this live webcast, except as may be required by applicable securities law.
With that said, I would like to turn the call over to Kevin Boyle. Kevin?